- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05871450
Legacy of the Special Olympics World Games Berlin 2023
August 27, 2025 updated by: German University of Health and Sports
This research aims to evaluate the impact of the project "170 Nations - 170 Inclusive Communities" of the Special Olympics World Games 2023 (SOWG 23) on sustain inclusive structures for people with intellectual disabilities (ID).
The research utilizes a quasi-experimental research design and a qualitative research design and will synthesize qualitative and quantitative data to display successful and non-successful interventions for more inclusive communities.
The research will target 56 host communities of SOWG 23 and 56 non-host communities, interviewing 200 people with ID and a minimum of 400 key stakeholders, as well as conducting qualitative interviews and focus groups.
Study Overview
Study Type
Interventional
Enrollment (Actual)
700
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10587
- German University of Health and Sport
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- legal age
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participants living in Host Towns
Participants live in Host Towns, where a delegation of athletes are hosted for one week.
Furthermore, Host Town coordinator organize several inclusive events.
|
Inclusive events such as inclusive sport festivals, citizen festivals or working groups at school are organized
|
|
No Intervention: Participants not living in Host Towns
Participants where no delegeation of athletes are hosted and no inclusive events are organized by Host Town coordinator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attitudes Measured With the ATTID-Questionnaire
Time Frame: Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)
|
The ATTID-SF Questionnaire encompassing three core components.
The affective component refers to emotional responses toward individuals with intellectual disabilities.
The cognitive component encompasses beliefs, knowledge, and perceptions about this population.
The behavioral component reflects self-reported actions.
The short form comprises 35 items rated on a 5-point Likert scale (1 = strongly agree to 5 = strongly disagree), with higher scores indicating more negative attitudes.
Items are grouped into five factors: (1) interaction, (2) sensitivity/tenderness, (3) discomfort, (4) knowledge about abilities, and (5) knowledge about causes of intellectual disabilities.
Mean scores are calculated for each factor; however, due to the scale's factor structure, an overall score is not recommended.
So the minimum mean score for each factor is 1, the maximum means score is 5.
|
Change from baseline (T1) attitudes toward people with intellectual disability (ATTID-Questionnaire) at 3-4 month (T2) and 8-9 month (T3)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Wolfgang Ruf, PhD, German University of Health and Sports
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
June 30, 2024
Study Registration Dates
First Submitted
May 4, 2023
First Submitted That Met QC Criteria
May 12, 2023
First Posted (Actual)
May 23, 2023
Study Record Updates
Last Update Posted (Estimated)
August 28, 2025
Last Update Submitted That Met QC Criteria
August 27, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SOWG Studie
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inclusion, Social
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body Myositis (sIBM)United States
-
Western University, CanadaProvidence Care Hospital, Kingston, ON, Canada; Trellis HIV and Community Care...Active, not recruitingSubstance Use Disorders | Mental Illness | Social InclusionCanada
-
Abcuro, Inc.Active, not recruitingInclusion Body Myositis (IBM)United States, Australia
-
University of Southern DenmarkOdense University HospitalCompleted
-
Oslo University HospitalThe Dam Foundation; The Norwegian Rheumatism AssociationCompletedFeasibility Study | Inclusion Body Myositis (IBM)Norway
-
CHU de ReimsCompletedClinical Research InclusionFrance
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Regeneron PharmaceuticalsWithdrawnSporadic Inclusion Body Myositis
-
Phoenix Neurological Associates, LTDUnknown
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body MyositisUnited States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Clinical Trials on Inclusive events
-
Emory UniversityAmerican Heart Association; National Center for Advancing Translational Sciences... and other collaboratorsRecruiting
-
Rush University Medical CenterWake Forest University Health Sciences; University of Wisconsin, Milwaukee; Children... and other collaboratorsCompletedPregnancy Related | Parent-Child Relations | Parenting | Education | Antenatal Care | CounselingUnited States
-
The Nethersole School of NursingNot yet recruiting
-
University of Maryland, College ParkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPeer Group | Social Exclusion | Prejudice, Racial | Prejudice | SexismUnited States
-
Zehra GürsoyCompletedPregnancy | Male | Breastfeeding Education | Breastfeeding Support | Parental SupportTurkey
-
University of British ColumbiaCompleted
-
Peking UniversityCompleted
-
University Hospital, AngersCémavieCompletedGeriatric DisordersFrance
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompleted
-
Uppsala UniversityThe Swedish Research CouncilRecruiting